A step towards a new drug to treat fungal infections that kill 1.6 million people annually

October 10, 2017
Yellow highlights the differences in fungal Arg1 that can be exploited for drug development. Credit: Professor Joel Mackay, School of Life and Environmental Sciences at the University of Sydney

A team from Sydney's Westmead Institute for Medical Research is a step closer to developing a drug to treat life-threatening fungal infections that cause more than 1.6 million deaths annually.

Death rates due to are similar to those of tuberculosis and greater than those due to malaria.

The team discovered that Arg1, a protein produced by all , enables the Cryptococcus neoformans fungus to establish potentially lethal infections in patients with , such as those with HIV/AIDS or leukaemia.

Lead researcher, Associate Professor Julianne Djordjevic, said she is optimistic this discovery will provide a new avenue for the development of safer urgently needed antifungal drugs.

"Finding new treatments to kill fungi is a major health priority. Novel antifungal drugs are desperately needed to reduce the high global morbidity, mortality and cost associated with treating invasive fungal infections.

"Because fungi are so similar to human cells, developing new drugs that kill fungi - but are non-toxic to humans - is a challenge. Furthermore not all kill all types of fungi and -resistance is an emerging problem.

"By investigating how fungi cause disease, we have identified a new drug target with the view to design new therapies to combat these serious infections," she said.

Cryptococcus neoformans is the world's most common cause of fungal meningitis.

The primary site of is the lung. After inhalation from the environment, the infection spreads from the lung to the brain via the bloodstream.

Immunosuppressed patients typically present with meningitis, which is fatal without treatment.

Associate Professor Djordjevic and her team identified the Arg1 protein as part of their investigation of the mechanisms that fungi exploit to cause life-threatening infections in the body.

"Our laboratory has established reliable methods for studying Cryptococcus neoformans at the molecular level.

"Using gene deletion analysis and animal infection models, we identified that the Arg1 metabolic pathway allows Cryptococcus to establish a and to spread to brain, resulting in meningitis.

"We are now looking at Arg1 as a selective target for antifungal drug development. By targeting Arg1, we hope to block the Arg1 metabolic pathway and thereby prevent Cryptococcus from establishing a lung infection and spreading to the brain," Associate Professor Djordjevic explained.

Associate Professor Djordjevic said that even with appropriate treatment, high mortalities are reported highlighting the need to develop more effective antifungal therapies.

"Fungal diseases are a growing global health problem and a leading cause of blindness, respiratory disease, meningitis and death.

"Treatments with fewer side effects will significantly increase the chances of recovery for a patient, potentially saving thousands of lives every year," Associate Professor Djordjevic concluded.

Explore further: New study targets lethal fungal infection

More information: Cecilia Li et al, IP3-4 kinase Arg1 regulates cell wall homeostasis and surface architecture to promote clearance of Cryptococcus neoformans infection in a mouse model, Virulence (2017). DOI: 10.1080/21505594.2017.1385692

Related Stories

New study targets lethal fungal infection

July 24, 2017
The development of new drugs to fight a common fungal pathogen which kills half a million people globally each year is a step closer thanks to a University of Queensland-led study.

Study identifies a new way to prevent deadly fungal infection spreading to the brain

August 23, 2017
Research at the University of Sheffield has identified how the behaviour of an infection can be changed to prevent serious disease.

Mice found able to ward off fungal lung infections by causing fungus to kill itself

September 8, 2017
(Medical Xpress)—A team of researchers from the U.S., Germany and Israel has found that mice are able to ward off fungal lung infections because their immune systems cause fungal spores to die. In their paper published ...

Researchers help develop new antifungal drug

October 6, 2017
University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.

Fungal disease spreads through UK hospitals – here's what you need to know about _Candida auris_

August 18, 2017
At least 20 NHS Trust hospitals have been hit by a drug-resistant fungus, Candida auris. So far, 200 people have been contaminated or infected with the fungus, which can cause potentially deadly complications.

Recommended for you

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.